Mednet Logo
HomeEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

In adults ≥80 years with TSH 6–10 mIU/L and minimal symptoms, do you initiate levothyroxine, monitor, or avoid treatment entirely?

1
2 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Beth Israel Deaconess Medical Center

I tend to check free T4 in this situation. Aging is associated with some elevation in TSH value up to 10 mIU/L with normal free T4, and in those patients, levothyroxine is not needed. In some patients, I have seen it rise above 10 with normal free T4. Supplementing levothyroxine to lower serum TSH w...

Can autoimmune thyroiditis present with recurrent angioedema and bronchospasm?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Oregon Health Sciences University Portland State University School Of Public Hea

There is an association between angioedema and autoimmune thyroid disease, although the incidence is not known. Activated CD4+ T lymphocytes, monocytes, and eosinophils. The incidence of thyroid autoimmunity in chronic urticaria is similar to the background population, but there is a cluster of angi...

Is there any role for bisphosphonate or alternative bone-modifying agents use in SMM in the absence of other indications for its use?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Harvard Medical School

The short answer is no, unless the patient has an indication like osteoporosis. Bisphosphonates have been evaluated in smoldering multiple myeloma in studies performed over 10 years ago. Treatment with pamidronate (D’Arena et al., 2011) or zoledronic acid (Musto et al., 2008) did not affect the time...

Would you start a mineralocorticoid receptor antagonist in patients with unilateral primary aldosteronism while they are awaiting adrenalectomy?

3 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Department Of Endocrinology Diabetes And Metabolism

It depends on their blood pressure and potassium levels. Some of our patients are already on MRA at the time of their diagnosis without a need to get off the medication. Others may be started or returned to MRA after completing their biochemical workup. We recommend stopping MRA on the day of surger...

How do you explain the use of an AI scribe to patients the first time it is used in their care?

9
5 Answers

Mednet Member
Mednet Member
Psychiatry · Private Practice

In residency, we had to get patient permission to videotape sessions and allow our supervisors to watch sessions from behind a one-way mirror. If I were to use a scribe, especially an AI scribe, or if I were audio or video taping the sessions, I would definitely want to get a patient’s approval. I d...

In patients with iron deficiency due to history of gastric bypass or IBD, would you consider oral iron therapy if the iron deficiency anemia is mild?

1
5 Answers

Mednet Member
Mednet Member
Hematology · Gundersen Health

Oral iron can often be effective in iron deficiency, as long as absorption is intact. If you are concerned about absorption, performing an oral iron challenge can be useful in allowing you to avoid long trials of oral iron that will be ineffective. Simply check an iron panel at baseline, then admini...

In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?

2
5 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

If LDL levels are already below 70, I don’t target a lower goal. The SPARCL trial showed that reducing LDL to this range has an NNT of about 45 to prevent one stroke, which I find to be modest at best. From my perspective, lowering LDL further (&lt;30-50 range) shifts the focus to treating a number rat...

When starting GLP-1 R agonist therapy for weight loss purposes, how do you counsel patients on duration of treatment therapy?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Emory University School of Medicine

I counsel people that I expect this to be lifelong therapy (similar to how we don't stop blood pressure medications when blood pressure comes down to normal on them because it will go back up, we don't stop GLP1RA when we get to our weight goals, as our weight will go back up when they are stopped)....

What is your approach to diagnosing insulin allergy in patients with diabetes?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Michigan State University College of Human Medicine

Insulin allergy, though uncommon since the advent of recombinant human insulin (estimated prevalence ~2%), remains a serious clinical concern. It can manifest as type I (IgE-mediated), type III (immune complex-mediated), or type IV (T-cell-mediated) hypersensitivity, ranging from local cutaneous rea...

How do you approach osteoporosis screening in men?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · University of California, Irvine

While osteoporosis is more prevalent in postmenopausal women, it is often under-recognized in men. The risk of mortality after hip fracture is higher in men, and that risk may extend over 10 years after injury. Men who sustain a wrist fracture are more likely to have severe osteoporosis and a higher...